{{Translating|||time=2017-04-30T15:11:13+00:00}}
{{Drugbox
| verifiedrevid = 464387150
| IUPAC_name = (2''S'')-''N''-[(2''S'',3''R'')-4-[(3''S'')-3-(''tert''-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide
| image = Saquinavir structure.svg
| width = 250
| image2 = Saquinavir ball-and-stick.png

<!--Clinical data-->
| tradename = Invirase, Fortovase
| Drugs.com = {{drugs.com|monograph|saquinavir}}
| MedlinePlus = a696001
| pregnancy_category = B1 (Australia)

<!--Pharmacokinetic data-->
| bioavailability = ~4% (without ritonavir [[Ritonavir#Mechanism_of_action|boosting]])<ref>{{cite web|title=Invirase (saquinavir mesylate) Capsules and Tablets, for Oral Use. Full Prescribing Information|url=http://www.gene.com/download/pdf/Invirase%20PI%20November%202012%20(1).pdf|publisher=Genentech, Inc|accessdate=23 November 2015}}</ref>
| metabolism = Hepatic, mainly by [[CYP3A4|CYP3A4]]
| protein_bound = 98%
| elimination_half-life = 9–15 hours
| excretion = feces (81%) and urine (3%)

<!--Identifiers-->
| IUPHAR_ligand = 4813
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 127779-20-8
| ATC_prefix = J05
| ATC_suffix = AE01
| PubChem = 441243
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01232
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 390016
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = L3JE09KZ2F
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00429
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 114
| NIAID_ChemDB = 000640

<!--Chemical data-->
| C=38 | H=50 | N=6 | O=5
| molecular_weight = 670.841 g/mol
| smiles = O=C(N)C[C@H](NC(=O)c1nc2c(cc1)cccc2)C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN5[C@H](C(=O)NC(C)(C)C)C[C@@H]4CCCC[C@@H]4C5
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QWAXKHKRTORLEM-UGJKXSETSA-N
}}
'''沙奎那維'''（{{lang|en|saquinavir}}），商品名'''Invirase'''和'''Fortovase'''，為一種[[抗反轉錄病毒藥物|抗反轉錄病毒藥物]]，可與其他藥物合併治療[[愛滋病|愛滋病]]<ref name="AHFS2015">{{cite web|title=Saquinavir|url=http://www.drugs.com/monograph/saquinavir.html|publisher=The American Society of Health-System Pharmacists|accessdate=Sep 5, 2015}}</ref>。通常會與{{le|ritonavir|ritonavir}}或[[快利佳|快利佳]]合併使用，該藥屬於口服藥物<ref name="AHFS2015" />。<!-- Side effects and mechanism -->

常見副作用包和噁心、嘔吐、腹瀉，以及疲憊。嚴重副作用則包含[[長QT症|長QT症]]、{{le|心阻斷|Heart block}}、[[高脂血症|高脂血症]]，以及肝臟問題。妊娠期間用藥目前顯示安全。本藥物屬於[[蛋白酶抑制劑|蛋白酶抑制劑]]，可抑制{{le|HIV蛋白酶|HIV protease}}的作用<ref name="AHFS2015" />。

<!-- Society and culture -->
沙奎那維於1995年首次上市[2]，並列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一。<ref name=Min2006>{{cite book|last1=Minor|first1=Lisa K.|title=Handbook of Assay Development in Drug Discovery.|date=2006|publisher=CRC Press|location=Hoboken|isbn=9781420015706|page=117|url=https://books.google.ca/books?id=RmrLBQAAQBAJ&pg=PA117}}</ref><ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015}}</ref> 本品迄今仍非[[學名藥|學名藥]]，因此價格相當昂貴。<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=72}}</ref> 一日劑量的批發價約為4.50美金左右。<ref name=ERC2014>{{cite web|title=Saquinavir|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=SAQ500T&s_year=2014&year=2014&str=500%20mg&desc=Saquinavir&pack=new&frm=TAB-CAP&rte=PO&class_code2=06%2E4%2E2%2E3&supplement=&class_name=%2806%2E4%2E2%2E3%29Protease%20inhibitors%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=6 September 2015}}{{Dead link|date=2018年6月 |bot=InternetArchiveBot |fix-attempted=no }}</ref>

==參考文獻==
<references/>

==外部連結==
* [http://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ROC Saquinavir bound to proteins] in the [[Protein_Data_Bank|PDB]]

[[分类:氨甲酰|分类:氨甲酰]]
[[Category:HIV_protease_inhibitors|Category:HIV protease inhibitors]]
[[分类:异喹啉|分类:异喹啉]]
[[分类:喹啉|分类:喹啉]]
[[Category:RTT|Category:RTT]]
[[分类:世界卫生组织基本药物|分类:世界卫生组织基本药物]]